Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(3.35)
# 963
Out of 4,650 analysts
204
Total ratings
45.36%
Success rate
3.71%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TYRA Tyra Biosciences | Maintains: Buy | $30 → $32 | $19.89 | +60.88% | 14 | Oct 28, 2024 | |
| LYEL Lyell Immunopharma | Reiterates: Neutral | $1 | $0.94 | +6.84% | 9 | Oct 28, 2024 | |
| HALO Halozyme Therapeutics | Reiterates: Buy | $65 | $50.46 | +28.81% | 25 | Oct 25, 2024 | |
| ZURA Zura Bio | Reiterates: Neutral | $5 | $4.61 | +8.46% | 2 | Oct 21, 2024 | |
| KRRO Korro Bio | Maintains: Buy | $100 → $115 | $63.85 | +80.11% | 8 | Oct 18, 2024 | |
| RANI Rani Therapeutics Holdings | Reiterates: Buy | $9 | $2.31 | +289.61% | 13 | Oct 18, 2024 | |
| ALMS Alumis | Initiates: Buy | $30 | $11.99 | +150.21% | 1 | Oct 17, 2024 | |
| LEGN Legend Biotech | Reiterates: Buy | $73 | $45.30 | +61.15% | 30 | Oct 16, 2024 | |
| MGX Metagenomi | Reiterates: Buy | $7 | $2.00 | +250.00% | 6 | Oct 15, 2024 | |
| ORKA Oruka Therapeutics | Initiates: Buy | $45 | $30.30 | +48.51% | 1 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $22.24 | +102.34% | 9 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $1.04 | +476.92% | 12 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $7 | $5.32 | +31.58% | 4 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $120 | $35.29 | +240.04% | 11 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.01 | - | 5 | Sep 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $22.30 | +101.79% | 12 | Sep 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $9 | $1.40 | +542.86% | 13 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $21 | $9.83 | +113.63% | 3 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $51 → $49 | $45.93 | +6.68% | 10 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $5.94 | +152.53% | 2 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.00 | +702.25% | 10 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $2,440 | $0.72 | +341,158.74% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18,000 → $14,000 | $1.70 | +823,429.41% | 2 | Apr 27, 2023 |
Tyra Biosciences
Oct 28, 2024
Maintains: Buy
Price Target: $30 → $32
Current: $19.89
Upside: +60.88%
Lyell Immunopharma
Oct 28, 2024
Reiterates: Neutral
Price Target: $1
Current: $0.94
Upside: +6.84%
Halozyme Therapeutics
Oct 25, 2024
Reiterates: Buy
Price Target: $65
Current: $50.46
Upside: +28.81%
Zura Bio
Oct 21, 2024
Reiterates: Neutral
Price Target: $5
Current: $4.61
Upside: +8.46%
Korro Bio
Oct 18, 2024
Maintains: Buy
Price Target: $100 → $115
Current: $63.85
Upside: +80.11%
Rani Therapeutics Holdings
Oct 18, 2024
Reiterates: Buy
Price Target: $9
Current: $2.31
Upside: +289.61%
Alumis
Oct 17, 2024
Initiates: Buy
Price Target: $30
Current: $11.99
Upside: +150.21%
Legend Biotech
Oct 16, 2024
Reiterates: Buy
Price Target: $73
Current: $45.30
Upside: +61.15%
Metagenomi
Oct 15, 2024
Reiterates: Buy
Price Target: $7
Current: $2.00
Upside: +250.00%
Oruka Therapeutics
Oct 7, 2024
Initiates: Buy
Price Target: $45
Current: $30.30
Upside: +48.51%
Oct 4, 2024
Reiterates: Buy
Price Target: $45
Current: $22.24
Upside: +102.34%
Oct 1, 2024
Reiterates: Buy
Price Target: $6
Current: $1.04
Upside: +476.92%
Sep 19, 2024
Reiterates: Neutral
Price Target: $7
Current: $5.32
Upside: +31.58%
Sep 17, 2024
Reiterates: Buy
Price Target: $120
Current: $35.29
Upside: +240.04%
Sep 13, 2024
Reiterates: Neutral
Price Target: n/a
Current: $1.01
Upside: -
Sep 13, 2024
Reiterates: Buy
Price Target: $45
Current: $22.30
Upside: +101.79%
Aug 15, 2024
Maintains: Buy
Price Target: $11 → $9
Current: $1.40
Upside: +542.86%
Aug 13, 2024
Maintains: Buy
Price Target: $22 → $21
Current: $9.83
Upside: +113.63%
Aug 12, 2024
Maintains: Buy
Price Target: $51 → $49
Current: $45.93
Upside: +6.68%
Aug 12, 2024
Reiterates: Buy
Price Target: $15
Current: $5.94
Upside: +152.53%
Jun 28, 2024
Reiterates: Buy
Price Target: $8
Current: $1.00
Upside: +702.25%
Sep 6, 2023
Maintains: Buy
Price Target: $160 → $2,440
Current: $0.72
Upside: +341,158.74%
Apr 27, 2023
Maintains: Buy
Price Target: $18,000 → $14,000
Current: $1.70
Upside: +823,429.41%